Healthcare Provider Discrimination toward Pregnant Women with Rifampin-Resistant Tuberculosis

Little is known about the treatment experiences of pregnant women with rifampin-resistant tuberculosis. We conducted qualitative interviews with 10 women who had this condition; 9 reported facing discrimination from healthcare providers. Our findings underscore an urgent need to ensure a human-right...

Descripción completa

Detalles Bibliográficos
Autores principales: Loveday, Marian, Hlangu, Sindisiwe, Furin, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2019
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390748/
https://www.ncbi.nlm.nih.gov/pubmed/30789334
http://dx.doi.org/10.3201/eid2503.181571
_version_ 1783398201935527936
author Loveday, Marian
Hlangu, Sindisiwe
Furin, Jennifer
author_facet Loveday, Marian
Hlangu, Sindisiwe
Furin, Jennifer
author_sort Loveday, Marian
collection PubMed
description Little is known about the treatment experiences of pregnant women with rifampin-resistant tuberculosis. We conducted qualitative interviews with 10 women who had this condition; 9 reported facing discrimination from healthcare providers. Our findings underscore an urgent need to ensure a human-rights–based, patient-centered approach for women with rifampin-resistant tuberculosis who are pregnant.
format Online
Article
Text
id pubmed-6390748
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-63907482019-03-06 Healthcare Provider Discrimination toward Pregnant Women with Rifampin-Resistant Tuberculosis Loveday, Marian Hlangu, Sindisiwe Furin, Jennifer Emerg Infect Dis Research Letter Little is known about the treatment experiences of pregnant women with rifampin-resistant tuberculosis. We conducted qualitative interviews with 10 women who had this condition; 9 reported facing discrimination from healthcare providers. Our findings underscore an urgent need to ensure a human-rights–based, patient-centered approach for women with rifampin-resistant tuberculosis who are pregnant. Centers for Disease Control and Prevention 2019-03 /pmc/articles/PMC6390748/ /pubmed/30789334 http://dx.doi.org/10.3201/eid2503.181571 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Letter
Loveday, Marian
Hlangu, Sindisiwe
Furin, Jennifer
Healthcare Provider Discrimination toward Pregnant Women with Rifampin-Resistant Tuberculosis
title Healthcare Provider Discrimination toward Pregnant Women with Rifampin-Resistant Tuberculosis
title_full Healthcare Provider Discrimination toward Pregnant Women with Rifampin-Resistant Tuberculosis
title_fullStr Healthcare Provider Discrimination toward Pregnant Women with Rifampin-Resistant Tuberculosis
title_full_unstemmed Healthcare Provider Discrimination toward Pregnant Women with Rifampin-Resistant Tuberculosis
title_short Healthcare Provider Discrimination toward Pregnant Women with Rifampin-Resistant Tuberculosis
title_sort healthcare provider discrimination toward pregnant women with rifampin-resistant tuberculosis
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390748/
https://www.ncbi.nlm.nih.gov/pubmed/30789334
http://dx.doi.org/10.3201/eid2503.181571
work_keys_str_mv AT lovedaymarian healthcareproviderdiscriminationtowardpregnantwomenwithrifampinresistanttuberculosis
AT hlangusindisiwe healthcareproviderdiscriminationtowardpregnantwomenwithrifampinresistanttuberculosis
AT furinjennifer healthcareproviderdiscriminationtowardpregnantwomenwithrifampinresistanttuberculosis

Ejemplares similares